Medical Devices: Reducing Import Dependence Through Manufacturing
PLI incentives and localisation are building a domestic medical-device base in a heavily import-dependent market.
Market Size
~$14–15 Bn (India, FY26E)
Growth
~15% CAGR (FY26–30E)
Read
6 min
Published
Jun 2026
Overview
India's medical-device market is large and growing but heavily import-dependent, spanning consumables, diagnostics equipment, implants, imaging and patient monitoring. Government PLI schemes and medical-device parks aim to localise manufacturing and reduce import reliance. Rising healthcare access, insurance and an ageing population expand device demand.
The nearer-term localisation wins are in consumables and lower-complexity devices, while high-end imaging and implants remain import-led. Regulatory formalisation under the medical-device rules is professionalising the sector and raising quality standards. Domestic champions are emerging in diagnostics equipment, cardiac devices and consumables.
The opportunity blends import-substitution and structural demand growth, but competing with established global majors on high-end technology is challenging. Localisation success depends on quality, scale and clinical acceptance.
Illustrative projection from the report's stated market size (~$14–15 Bn (India, FY26E)) and growth (~15% CAGR (FY26–30E)).
Key Highlights
- Heavy import dependence creating localisation opportunity
- PLI schemes and device parks supporting manufacturing
- Consumables and diagnostics as nearer-term wins
- Regulatory formalisation raising quality standards
Growth Drivers
- PLI incentives and import-substitution push
- Rising healthcare access and insurance
- Ageing population and chronic-disease burden
- Regulatory formalisation professionalising the sector
Key Players
Investment Outlook
Medical devices offer a blend of import-substitution and demand growth, with nearer-term returns in consumables and diagnostics. We favour domestic players with quality credentials and scale in localisable categories rather than those competing head-on in high-end imaging.
Key Risks
- Competition from established global majors in high-end devices
- Regulatory and clinical-acceptance hurdles
- Import dependence for key components and technology
The Neoma View
We favour device makers scaling in localisable, quality-sensitive categories; we are more cautious where domestic players must out-innovate entrenched global majors.
Talk to an advisor →All figures are indicative and for information only - not investment advice or a recommendation. Market sizes, growth rates and financial metrics are hedged estimates that vary by source and period. Please consult your advisor before investing.
More in Healthcare
Digital Health & Telemedicine
Digital Health & Telemedicine: The Long Road to Scalable Profitability in India's Fragmented Healthcare Landscape
India's digital health sector is poised for substantial growth, driven by increasing internet penetration and a demand for accessible healthcare, yet faces a complex path to sustained profitability amidst intense competition and evolving regulations.
CDMO & Pharma Contract Manufacturing
CDMO & Pharma Contract Manufacturing: India's Ascent in Complex Molecules and Global Supply Chains
India's CDMO sector is poised for robust growth, driven by global outsourcing trends, increasing R&D complexity, and a strategic shift towards higher-value, specialized molecules.
Biosimilars & Biologics
Biosimilars & Biologics: India's Ascent in Complex Biopharmaceuticals - Navigating Global Patent Cliffs and Domestic Demand
India's biopharmaceutical sector is poised for substantial growth, driven by an expanding biosimilar pipeline targeting global patent expiries and increasing domestic demand for advanced biologics, creating a nuanced investment landscape.